Jun 18 |
Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
|
Jun 13 |
Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.
|
Jun 7 |
Scinai Immunotherapeutics regains Nasdaq compliance
|
Jun 7 |
Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement
|
May 27 |
Scinai Immunotherapeutics gets non-compliance notice from Nasdaq
|
May 24 |
Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance
|
May 16 |
Scinai Immunotherapeutics reports FY results
|
May 15 |
Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update
|
May 6 |
Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal
|
Apr 8 |
Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services
|